CN101099852B - 治疗慢性病毒性肝炎的中药组合物及其制备方法 - Google Patents
治疗慢性病毒性肝炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN101099852B CN101099852B CN2007101452843A CN200710145284A CN101099852B CN 101099852 B CN101099852 B CN 101099852B CN 2007101452843 A CN2007101452843 A CN 2007101452843A CN 200710145284 A CN200710145284 A CN 200710145284A CN 101099852 B CN101099852 B CN 101099852B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- pulvis
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 230000001684 chronic effect Effects 0.000 title claims abstract description 25
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 206010019799 Hepatitis viral Diseases 0.000 title claims abstract description 22
- 201000001862 viral hepatitis Diseases 0.000 title claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000002775 capsule Substances 0.000 claims description 24
- 241000209020 Cornus Species 0.000 claims description 20
- 210000003038 endothelium Anatomy 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 9
- 241000407170 Curcuma Species 0.000 claims description 8
- 235000014375 Curcuma Nutrition 0.000 claims description 8
- 241000545442 Radix Species 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 239000012567 medical material Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 230000008719 thickening Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 20
- 235000004415 Burchellia bubalina Nutrition 0.000 abstract 3
- 240000008537 Burchellia bubalina Species 0.000 abstract 3
- 239000000463 material Substances 0.000 abstract 2
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 abstract 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 239000010135 fructus aurantii immaturus Substances 0.000 abstract 1
- 229940016667 resveratrol Drugs 0.000 abstract 1
- 235000021283 resveratrol Nutrition 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 24
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 17
- 239000010931 gold Substances 0.000 description 17
- 229910052737 gold Inorganic materials 0.000 description 17
- 241000208340 Araliaceae Species 0.000 description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 description 16
- 229940079593 drug Drugs 0.000 description 16
- 235000008434 ginseng Nutrition 0.000 description 16
- 239000003826 tablet Substances 0.000 description 13
- 206010008909 Chronic Hepatitis Diseases 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 208000006454 hepatitis Diseases 0.000 description 11
- 208000002672 hepatitis B Diseases 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 7
- 239000009636 Huang Qi Substances 0.000 description 6
- 206010019755 Hepatitis chronic active Diseases 0.000 description 5
- 206010019759 Hepatitis chronic persistent Diseases 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 206010019847 hepatosplenomegaly Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 101710142246 External core antigen Proteins 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- -1 electuary Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 238000007449 liver function test Methods 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- JMZOMFYRADAWOG-UHFFFAOYSA-N methyl 7-methoxy-4-(7-methoxy-5-methoxycarbonyl-1,3-benzodioxol-4-yl)-1,3-benzodioxole-5-carboxylate Chemical compound COC(=O)C1=CC(OC)=C2OCOC2=C1C1=C2OCOC2=C(OC)C=C1C(=O)OC JMZOMFYRADAWOG-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000011287 therapeutic dose Methods 0.000 description 2
- LCTORNIWLGOBPB-PHYPRBDBSA-N (2s,3r,4s,5r,6r)-2-amino-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound N[C@@]1(O)O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O LCTORNIWLGOBPB-PHYPRBDBSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 241000984642 Cura Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 206010041519 Spider naevus Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 229940071462 oralone Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101452843A CN101099852B (zh) | 2007-08-21 | 2007-08-21 | 治疗慢性病毒性肝炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101452843A CN101099852B (zh) | 2007-08-21 | 2007-08-21 | 治疗慢性病毒性肝炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101099852A CN101099852A (zh) | 2008-01-09 |
CN101099852B true CN101099852B (zh) | 2010-08-11 |
Family
ID=39034405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101452843A Active CN101099852B (zh) | 2007-08-21 | 2007-08-21 | 治疗慢性病毒性肝炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101099852B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102824613B (zh) * | 2012-09-20 | 2014-01-01 | 新乡医学院第一附属医院 | 金参疏肝胶囊在制备平喘药物中的应用 |
CN104721321A (zh) * | 2015-04-13 | 2015-06-24 | 赵丛旭 | 一种治疗病毒性肝炎的中药 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1371714A (zh) * | 2002-03-25 | 2002-10-02 | 孟范英 | 愈肝散 |
CN1371713A (zh) * | 2002-03-25 | 2002-10-02 | 刘振顺 | 一粒丹 |
-
2007
- 2007-08-21 CN CN2007101452843A patent/CN101099852B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1371714A (zh) * | 2002-03-25 | 2002-10-02 | 孟范英 | 愈肝散 |
CN1371713A (zh) * | 2002-03-25 | 2002-10-02 | 刘振顺 | 一粒丹 |
Non-Patent Citations (2)
Title |
---|
彭海燕等.中医药治疗原发性肝癌的现状与展望.中西医结合肝病杂志16 3.2006,16(3),184-187. |
彭海燕等.中医药治疗原发性肝癌的现状与展望.中西医结合肝病杂志16 3.2006,16(3),184-187. * |
Also Published As
Publication number | Publication date |
---|---|
CN101099852A (zh) | 2008-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103099902B (zh) | 治疗亚急性甲状腺炎的中药组合物及其制备方法 | |
WO2021120972A1 (zh) | 一种治疗气血两虚症候的中药组合物及其制备方法和应用 | |
CN100496589C (zh) | 一种治疗和预防神经官能症的药物及其制备方法 | |
CN102397372A (zh) | 一种药物组合物及制剂和其在治疗肠易激综合征中的应用 | |
CN1686511A (zh) | 具有疏肝健脾、养血调经丹栀逍遥的药物及其制备方法 | |
CN101371915A (zh) | 一种小柴胡汤制剂的制备方法 | |
CN102188634B (zh) | 一种治疗高尿酸血症的中药组合物 | |
CN102302608B (zh) | 一种治疗贫血的中药组合物及其制备方法 | |
CN101099852B (zh) | 治疗慢性病毒性肝炎的中药组合物及其制备方法 | |
CN102657736B (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法 | |
CN1927324A (zh) | 用于治疗妇女月经不调中药制剂的制备方法 | |
CN102552512A (zh) | 一种治疗乙肝的中药组合物 | |
CN101810671B (zh) | 一种治疗艾滋病的中药制剂及其制备方法 | |
CN101695562B (zh) | 一种治疗病毒性肝炎的中药组合物及其制备方法 | |
CN1943718B (zh) | 一种中药组合物及其制备方法 | |
CN107823487B (zh) | 一种治疗非酒精性脂肪肝的中药组合物及其制备方法与应用 | |
CN1814250B (zh) | 一种治疗肝硬化腹水的中药组合物及其制备方法 | |
CN102488851B (zh) | 治疗反复发作生殖器疱疹的药物及其制备方法 | |
CN102940747B (zh) | 治疗痛风的药物组合物 | |
CN101618156A (zh) | 一种治疗乙型肝炎的药物组合物及其制备方法 | |
CN100382824C (zh) | 一种治疗慢性肝炎的中药及其制备方法 | |
CN100471488C (zh) | 一种温阳益气、养心安神的中药组合物及其制备方法 | |
CN101642485B (zh) | 一种含黄芪的药物组合物在制备治疗白细胞减少症、过敏性紫癜症的药物中的应用 | |
CN1333044A (zh) | 消渴降糖宝 | |
CN1049834C (zh) | 治疗肝炎的药物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Shengtai Pharmaceutical Co., Ltd., Harbin Assignor: Gao Xiang Contract record no.: 2011230000046 Denomination of invention: Chinese medicinal composition for treating chronic viral hepatitis and preparation thereof Granted publication date: 20100811 License type: Exclusive License Open date: 20080109 Record date: 20110727 |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Shengtai Pharmaceutical Co., Ltd., Harbin Assignor: Gao Xiang Contract record no.: 2011230000046 Date of cancellation: 20111020 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Harbin Shengtai Pharmaceutical Co., Ltd. Assignor: Gao Xiang Contract record no.: 2011230000302 Denomination of invention: Chinese medicinal composition for treating chronic viral hepatitis and preparation thereof Granted publication date: 20100811 License type: Exclusive License Open date: 20080109 Record date: 20111027 |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Harbin Shengtai Pharmaceutical Co., Ltd. Assignor: Gao Xiang Contract record no.: 2011230000302 Date of cancellation: 20120330 |
|
ASS | Succession or assignment of patent right |
Owner name: HARBIN SANCTITY BIOPHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: GAO XIANG Effective date: 20120511 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120511 Address after: 150025 No. 99 Beijing Road, Limin Development Zone, Heilongjiang, Harbin Patentee after: Harbin Shengtai Pharmaceutical Co., Ltd. Address before: 150025, 99 Beijing Road, Limin economic and Technological Development Zone, Heilongjiang, Harbin Patentee before: Gao Xiang |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140120 Address after: 150025 No. 99 Beijing Road, Limin Development Zone, Heilongjiang, Harbin Patentee after: HARBIN SANCTITY BIOLOGICAL PHARMACEUTICAL CO., LTD. Address before: 150025 No. 99 Beijing Road, Limin Development Zone, Heilongjiang, Harbin Patentee before: Harbin Shengtai Pharmaceutical Co., Ltd. |